Effect of Drug

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

FP
Fosun PharmaAustralia - Sydney
1 program
1
ORIN1001Phase 1/21 trial
Active Trials
NCT05154201CompletedEst. Jan 2025
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
PropofolN/A1 trial
Active Trials
NCT07162805CompletedEst. Oct 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fosun PharmaORIN1001
City TherapeuticsPropofol

Clinical Trials (2)

Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.

Start: Jul 2020Est. completion: Jan 2025
Phase 1/2Completed

Propofol Dose-Finding for Colonoscope Insertion in Geriatric Patients

Start: Sep 2025Est. completion: Oct 2025
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space